Blog
RSS FeedPosted by Michael Wonder on 02 Aug 2018
FDA and EMA to hold workshop on breakthrough therapy and PRIME designations
2 August 2018 - The US FDA and EMA will hold a workshop on early access approaches, including PRIME and ...
Posted by Michael Wonder on 07 Jun 2018
Public hearing on quinolones and fluoroquinolones: 23 speakers from 11 EU countries to share experience
7 June 2018 - Agenda and list of speakers for 13 June hearing available ...
Posted by Michael Wonder on 22 May 2018
Working together for people with rare and complex diseases
22 May 2018 - Live broadcast of workshop with European Reference Networks on 29 May. ...
Posted by Michael Wonder on 15 Apr 2018
Doctors, drug and tech experts converge on Halifax for symposium
13 April 2018 - As a frontline health-care provider and addictions specialist, Dr. David Martell sees the advent of drug ...
Posted by Michael Wonder on 19 Mar 2018
Workshop on paediatric regulation – stakeholders to discuss how to boost development of medicines for children
19 March 2018 - Event to be broadcast live on 20 March. ...
Posted by Michael Wonder on 31 Jan 2018
How to better apply the paediatric legislation to boost development of medicines for children
31 January 2018 - EMA and European Commission invite stakeholders to register for joint workshop and support development of an ...
Posted by Michael Wonder on 11 Sep 2017
How the EU regulates medicines
11 September 2017 - Awareness session for international regulators and NGOs on the work of EMA and European medicines regulatory ...
Posted by Michael Wonder on 27 Jul 2017
FDA sets inaugural meeting of first-ever patient engagement advisory committee
25 July 2017 - Imagine checking your blood sugar levels several times a day with a glucose meter to keep your ...
Posted by Michael Wonder on 03 Jul 2017
SMC industry engagement event
3 July 2017 - The SMC has announced details of the next Scottish Medicines Consortium Industry Engagement Event. ...
Posted by Michael Wonder on 08 May 2017
PDA/FDA Biosimilars Conference - 26-27 June 2017
3 May 2017 - The FDA and PDA are co-sponsoring a conference to identify best practices for global development and approval ...
Posted by Michael Wonder on 07 Mar 2017
Personalised medicines – focus on patients and healthcare professionals
7 March 2017 - EMA workshop will discuss role of patients, consumers and health care professionals. ...
Posted by Michael Wonder on 06 Mar 2017
Chronic obstructive pulmonary disorder review - stakeholder forum
6 March 2017 - A stakeholder forum will be held for the post-market review of chronic obstructive pulmonary disorder medicines on ...
Posted by Michael Wonder on 28 Feb 2017
Sinodinos announces intention for women's advisory roundtable
28 February 2017 - The newly-appointed Minister for Industry, Innovation and Science, Senator Arthur Sinodinos, has announced an intention to ...
Posted by Michael Wonder on 07 Feb 2017
Assessing the value of drugs for rare conditions: Institute for Clinical and Economic Review to host orphan drug assessment and pricing summit
7 February 2017 - Discussion will be anchored by an ICER Briefing Paper evaluating the evidence on the comparative clinical effectiveness ...
Posted by Michael Wonder on 24 Jan 2017
European Commission initiative improves information for patients on biosimilar medicines
23 January 2017 - For the third year in a row, the European Commission will organise a multi-stakeholder workshop on biosimilar ...